pharma news today obesity drug glp-1 Roche was among the first pharmaceutical companies to research drugs in the glucagon-like peptide-1 (GLP-1) class but abandoned the field after late-stage flops just before the latest boom began. Having Dozens of new obesity drugs
Pay in 4 interest-free payments of $6.54 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10























